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Metabotropic glutamate receptors (mGluRs) 1–8 are G protein-
coupled receptors (GPCRs) that modulate excitatory neurotransmis-
sion, neurotransmitter release, and synaptic plasticity. PKC regulates
many aspects of mGluR function, including protein–protein interac-
tions, Ca2 signaling, and receptor desensitization. However, the
mechanisms by which PKC regulates mGluR function are poorly
understood. We have now identified calmodulin (CaM) as a dynamic
regulator of mGluR5 trafficking. We show that the major PKC phos-
phorylation site on the intracellular C terminus of mGluR5 is serine 901
(S901), and phosphorylation of this residue is up-regulated in re-
sponse to both receptor and PKC activation. In addition, S901 phos-
phorylation inhibits mGluR5 binding to CaM, decreasing mGluR5
surface expression. Furthermore, blocking PKC phosphorylation of
mGluR5 on S901 dramatically affects mGluR5 signaling by prolonging
Ca2 oscillations. Thus, our data demonstrate that mGluR5 activation
triggers phosphorylation of S901, thereby directly linking PKC phos-
phorylation, CaM binding, receptor trafficking, and downstream
signaling.
phosphorylation  protein kinase C  receptor trafficking
The group I metabotropic glutamate receptor mGluR5 is highlyexpressed in the forebrain, where it regulates synaptic plasticity
(1, 2). In addition, mGluR5 plays a role in pain (3) and addiction
(4) and in neurological disorders such as fragile X syndrome (5, 6).
Group ImGluRs areG protein-coupled receptors (GPCRs), which
are coupled to phospholipase C, and receptor activation triggers
phosphoinositide turnover, release of intracellular Ca2, and acti-
vation of Protein Kinase C (PKC) (7). Although PKC activity
regulates mGluR5-mediated Ca2 signaling and receptor function
(8–11), there are no studies linking PKC phosphorylation of
mGluR5 to receptor surface expression, endocytosis, or intracel-
lular trafficking.
Like other GPCRs, mGluR5 interacts with many proteins in
addition to the guanine nucleotide-binding proteins (G proteins).
Most of the binding sites for these protein–protein interactions
reside within the long intracellular C-terminal domain of mGluR5,
suggesting that this region is critical in the functional regulation of
mGluR5. For example, the Homer proteins bind to the PPxxFR
motif within the distal C terminus, the Tamalin protein associates
with the distal C terminus, and calmodulin (CaM) and the E3 ligase
Siah-1A bind to the first one-third of the mGluR5 C terminus
(12–15). However, the dynamic regulation of these protein–protein
interactions has not been described. CaM is a particularly intriguing
candidate as an mGluR5 regulator because of its Ca2 dependence
and its key role in synaptic plasticity (16, 17). Furthermore, CaM
binding to other GPCRs, including dopamine, opioid, and seroto-
nin receptors, has been documented, consistent with a conserved
regulatory role for CaM in regulating GPCRs (18–20). We now
show that PKC phosphorylation of serine 901 (S901) on mGluR5
inhibits CaM binding and decreases mGluR5 surface expression.
Furthermore, preventing S901 phosphorylation led to a dramatic
increase in mGluR5-mediated Ca2 oscillations, revealing a direct
mechanistic link among mGluR5 activation, phosphorylation, traf-
ficking, and downstream signaling.
Results
We characterized the direct phosphorylation of mGluR5 by PKC
by using several biochemical techniques. GST fusion proteins
containing the proximal one-third of the mGluR5 C terminus
(GST–mGluR5–Cprox) were incubated with purified PKC in
vitro, and receptor phosphorylation was evaluated by using
phosphopeptide map analysis. There were multiple PKC phos-
phorylation sites, and mutation of S901 to alanine eliminated the
most prominent phosphopeptides, indicating that S901 is directly
phosphorylated by PKC (Fig. 1A). We also evaluated the phos-
phorylation of GST–mGluR5–Cprox by PKC by using mass
spectrometry, which unambiguously identified S901 as the pre-
dominant phosphorylation site (data not shown). HeLa cells
expressing Myc-tagged wild-type mGluR5 or mGluR5 S901A
were treated with the PKC activator phorbol 12-myristate 13-
acetate (PMA), and we observed phosphorylation of wild-type
mGluR5, but not mGluR5 S901A, by using a S901 phosphory-
lation state-specific antibody. Treating the cells with PMA to
stimulate PKC rapidly increased the phosphorylation of
mGluR5 on S901 (Fig. 1 B and C). Furthermore, application of
the mGluR5 agonist dihydroxyphenylglycol (DHPG) dramati-
cally increased S901 phosphorylation on mGluR5 in heterolo-
gous cells (Fig. 1 D and E). To examine S901 phosphorylation of
endogenous mGluR5, phosphorylated receptor was immunopre-
cipitated from cell lysates prepared from cultured hippocampal
neurons by using the S901 phosphorylation state-specific anti-
body in both nondenaturing and denaturing conditions. We
found that PKC activation increased S901 phosphorylation of
mGluR5 in hippocampal neurons (Fig. 1 F and G). In addition,
DHPG increased S901 phosphorylation, which was blocked by
the PKC inhibitor bisindolylmaleimide I, demonstrating that
agonist-induced S901 phosphorylation is mediated by PKC (Fig.
1 H–J).
S901 is located within a region of the mGluR5 C terminus that
contains a CaM-binding site (Fig. 2A), and previous studies have
shown that the CaM–mGluR5 interaction is regulated by PKC
phosphorylation in vitro (21). We, therefore, evaluated CaM bind-
ing to the mGluR5 C terminus by using a GST pull-down assay. As
anticipated, wild-type mGluR5 bound to CaM robustly, and the
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interaction was disrupted by PKC phosphorylation (Fig. 2A).
However, PKC-dependent inhibition of CaM binding to mGluR5
was eliminatedwhen S901 onmGluR5wasmutated to alanine (Fig.
2A), highlighting a central role for S901 in regulating CaM binding
to mGluR5. The CaM–mGluR5 interaction is abolished by the
addition of EGTA to the binding reaction mixture, indicating that
it is Ca2-dependent (Fig. 2A). We also performed coimmunopre-
cipitation experiments by using full-length mGluR5 and CaM
expressed in HeLa cells, and we found that mutation of S901 to
aspartic acid, a phosphomimetic mutation of S901, profoundly
Fig. 1. mGluR5 is phosphorylated by PKC on S901. (A) Wild-type GST–mGluR5–Cprox and GST–mGluR5–Cprox (S901A) were phosphorylated by PKC in vitro by using
[-32P]ATP and analyzed by 2D phosphopeptide mapping. (B–E) HeLa cells expressing wild-type Myc–mGluR5 or Myc–mGluR5 S901A were treated with PMA (1 M)
or DHPG (100 M) as indicated. mGluR5 was immunoprecipitated with Myc antibody, and S901-phosphorylated mGluR5 was detected by using rabbit S901
phosphoantibody. (F andG) Cultured hippocampal neurons were treated with PMA (1M for 10 min), S901-phosphorylated mGluR5 was immunoprecipitated under
nondenaturing and denaturing conditions, and proteins were immunoblotted with mGluR5 antibody. (H–J) Cultured hippocampal neurons were treated with DHPG
(100 M for 10 min) with or without preincubation with bisindolylmaleimide I (Bis I) (5 M for 30 min). S901-phosphorylated mGluR5 was immunoprecipitated, and
proteins were immunoblotted with mGluR5 antibody. Quantification of immunoblotting (C, E, G, and I) is depicted as a histogram including results from three
independent experiments. Statistical significance is indicated as ** (P 0.01).
Fig. 2. PKC phosphorylation of mGluR5 on S901 inhibits CaM binding. (A) S901 regulates mGluR5 binding to CaM. Wild-type and mutant GST-mGluR5 fusion proteins
were phosphorylated with or without PKC and incubated with recombinant CaM in the presence of CaCl2 or EGTA. Proteins were resolved by SDS/PAGE and
immunoblotted with CaM antibody or S901 phosphoantibody. A schematic figure shows the CaM-binding motif on the mGluR5 C terminus, and quantification is
depicted as a histogram (n 4). (B) HeLa cells were cotransfected with mGluR5 (wild-type, S901A, or S901D) and CaM–His. mGluR5 was immunoprecipitated from cell
lysates with mGluR5 antibody, resolved by SDS/PAGE, and immunoblotted with His antibody. Quantitative analysis of the blots is depicted as a histogram (n  3).
Statistical significance is indicated as ** (P 0.01).
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inhibited mGluR5 binding to CaM (Fig. 2B). Thus, these findings
identify phosphorylation of S901 as the critical mechanism regu-
lating mGluR5 binding to CaM.
We next directly examined the role of PKC phosphorylation and
CaM binding on the trafficking of mGluR5. We monitored the
trafficking of mGluR5 at or near the plasmamembrane in real time
by using total internal reflection fluorescencemicroscopy (TIRFM)
(Fig. 3A). Fluorescent spots of mGluR5–monomeric red fluores-
cent protein (mRFP)moved away from the plasmamembrane after
agonist treatment, consistent with agonist-induced endocytosis. In
contrast to wild-type mGluR5, the distribution of mGluR5 S901A
did not change significantly over time (Fig. 3B). By using an
ELISA-based assay, we found that the surface expression of wild-
type mGluR5 decreased over time with agonist exposure, whereas
the surface expression of mGluR5 S901A did not (Fig. 3C).
Therefore, our findings support a role for S901 phosphorylation in
regulating mGluR5 trafficking and surface expression. To mimic
S901 phosphorylation of the entire pool of mGluR5, we mutated
S901 to aspartic acid, a phosphomimetic mutation, and measured
surface expression of wild-type mGluR5 and mGluR5 S901D by
using a biotinylation assay. Compared to wild-type mGluR5, the
surface level of mGluR5 S901D was dramatically decreased (Fig. 3D).
Because S901 regulates binding of CaM, we explored whether
changes in CaM expression altered mGluR5 surface expression.
Fig. 3. Phosphorylation of S901 and CaM binding regulate mGluR5 trafficking and surface expression in heterologous cells. (A) TIRFM imaging of wild-type
mGluR5–mRFP in HeLa cells. Glutamate was applied to HeLa cells expressing mGluR5–mRFP, and the disappearance of mGluR5 fluorescence on or near the cell surface
was monitored over time. (B) Changes in the intensity of mGluR5–mRFP (wild-type or S901A) fluorescence from TIRFM images after glutamate application are depicted
in a line graph. (C) Surface expression of mGluR5 was analyzed in HeLa cells expressing wild-type Myc–mGluR5 or Myc–mGluR5 S901A, treated with or without
glutamate by using a quantitative colorimetric assay.*,P0.05;**,P0.01 compared with S901A plus glutamate. (D) Surface expression of mGluR5 (wild-type, S901A,
or S901D) was analyzed in HeLa cells by biotinylation. Surface-expressed proteins were isolated from cell lysates by using neutravidin agarose, and total lysates and
biotinylated fractions were immunoblotted with mGluR5 or actin antibodies. Surface-expressed mGluR5 was normalized by mGluR5 expression from total lysates.
Quantification is depicted as a histogram, including results from five independent experiments. **, P  0.01 compared with wild-type (S901S). (E) HeLa cells were
cotransfected with Myc–mGluR5 and CaM or Myc–mGluR5, and shRNA targeting CaM (shCAM) and mGluR5 surface expression was measured with a Myc antibody
(9E10)-based ELISA. Expression of endogenous CaM in HeLa cells was inhibited by expressing shRNAs targeting human Calm2 and Calm3 but not with the expression
of nontargeting control shRNA (Cont). Cell lysates were subjected to SDS/PAGE and immunoblotted with CaM or actin antibodies (Inset). (F) HeLa cells expressing
Myc–mGluR5 (wild-type or S901A) with or without CaM were incubated with glutamate. The surface expression of mGluR5 was quantitated by using a Myc
antibody-basedELISA.*,P0.05;**,P0.01comparedwithwild-typeplusglutamate. (G)HeLacells cotransfectedwithMyc–mGluR5(wild-typeorS901A)andshRNAs
targeting human Calm2 and Calm3 were treated with glutamate. The surface expression of mGluR5 was measured with a Myc antibody-based ELISA. **, P  0.01
compared with S901A plus glutamate.








Although overexpression or knockdown of CaM did not affect the
steady-state surface expression level of mGluR5 (Fig. 3E), overex-
pression of CaM inhibited agonist-induced changes in mGluR5
surface expression (Fig. 3F). Furthermore, knockdown of CaM by
using shRNA CaM decreased the surface expression of mGluR5
S901A after agonist exposure (Fig. 3G), a finding that was consis-
tent with the mGluR5 S901A effects on trafficking being a direct
result of increased CaM binding to the receptor.
We also examined the role of S901 phosphorylation and CaM
binding on the trafficking of mGluR5 expressed in hippocampal
neurons. By using a fluorescence-based antibody uptake assay, we
observed robust endocytosis (internalized receptor, green) and a
concomitant reduction in surface-expressed wild-type mGluR5
(surface, red) with agonist treatment (Fig. 4A). We found a
significant decrease in the amount of internalized mGluR5 S901A
compared to wild-type mGluR5 (Fig. 4 B and C). In addition,
cotransfection of mGluR5 with CaM resulted in a significant
decrease in mGluR5 endocytosis, for both wild-type mGluR5 and
mGluR5 S901A (Fig. 4 B and C). These findings demonstrate that
mGluR5 trafficking is regulated by S901 phosphorylation and CaM
binding in both heterologous cells and in neurons.
mGluR5 activation triggers Ca2 oscillations after agonist treat-
ment, and the frequency of the Ca2 spikes is correlated with
mGluR5 receptor density on the plasma membrane (8, 22). There-
fore, regulation of mGluR5 surface expression by S901 phosphor-
ylation is likely to affect mGluR5-initiated signaling. To test this
hypothesis, HeLa cells expressing mGluR5 (wild-type or S901A)
were loaded with fura-2-AM, and agonist-simulated Ca2 oscilla-
tion patterns were analyzed by using a ratiometric spectrofluoro-
photometer. Compared to wild-type mGluR5, mGluR5 S901A
showed an increase in Ca2 oscillation frequency (14.27  3.49
mHz for wild-type vs. 26.75 7.70 mHz for S901A; P 0.01) (Fig.
5A and B). The half-time for Ca2 to return to prestimulated levels
was also measured, revealing that mGluR5 S901A activation re-
sulted in more prolonged Ca2 oscillations compared to wild-type
mGluR5 (151.54 112.83 s for wild-type vs. 886.85 236.97 s for
S901A;P 0.01) (Fig. 5C). These data, therefore, demonstrate that
mGluR5 S901A-induced signaling is prolonged relative to that
observed in wild-type mGluR5-expressing cells.
Discussion
In this study, we have identified S901 as the major PKC phosphor-
ylation site on the intracellular C terminus of mGluR5. Phosphor-
ylation of S901 was dynamically regulated by PKC activity and
receptor activation. Importantly, we found that phosphorylation of
S901 profoundly inhibitedCaMbinding tomGluR5. In addition, we
found that PKC phosphorylation of S901 decreased mGluR5
surface expression, providing the first evidence that PKC activation
directly regulates mGluR5 trafficking. Furthermore, we show that
overexpression of CaM increases mGluR5 surface expression,
whereas knockdownofCaMdecreasesmGluR5 surface expression,
demonstrating that CaM specifically mediates the PKC-dependent
regulation of mGluR5 trafficking. Thus, we show that CaM stabi-
lizes the surface expression of a GPCR. Our findings are consistent
with a model in which mGluR5 surface expression is stabilized by
CaMbinding, but after receptor stimulation, PKCactivity increased
S901 phosphorylation, disruptedCaMbinding, and reducedmGluR5
surface expression (Fig. 6).
CaM interacts with a variety of proteins and, via these interac-
tions, regulates neuronal processes such as ion channel function (23,
24), GPCR signaling (18–20, 25), and synaptic plasticity (23–25).
CaMhas been shown to bind to severalGPCRs (18–21, 26–28), and
in some cases, CaM is implicated in the regulation of GPCR
trafficking. For example, agonist-induced endocytosis of the
5-HT1A receptor is prevented by pharmacological inhibitors of
CaM (29). In addition, CaM regulates the activity of G protein-
Fig. 4. Agonist-induced internalization of mGluR5 is
regulated by S901 and CaM binding in neurons. (A) Cul-
tured hippocampal neurons expressing Myc–mGluR5
were incubated with Myc antibody for 45 min at room
temperature. The neurons were incubated with DHPG at
37°C for 30 min as indicated. The surface (Sur) pool (red)
and internalized (Int) receptor (green) were visualized as
described in theMethodsand analyzed by laser scanning
confocal microscopy. The merge of the two signals is
shown. The region in the white box is shown at higher
magnification below. (B) Myc-tagged mGluR5 (wild-type
or S901A) was cotransfected with mRFP-tagged CaM or
mRFP only. The internalized pool (green) and surface
pool (red) are indicated. mRFP signal is shown as white
for clarification. (C) Quantification of the fluorescence
microscopy is presented as a histogram. The values indi-
cate internalization fraction as compared with the total.
The data represent means  SEM; n  180 neuronal
processes analyzed for DHPG and n 40 for control. **,
P 0.01.
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coupled receptor kinases, which play important roles in endocytosis
of GPCRs, suggesting an indirect role of CaM in regulating GPCR
trafficking (30, 31). Recent findings also show that CaM binding to
mGluR7 disrupts its interaction with the PDZ protein PICK1,
increasing mGluR7 endocytosis (32). We now describe the direct
stabilization of mGluR5 surface expression via CaM binding, and
these data are, to our knowledge, the first to describe the dynamic
regulation of GPCR trafficking by CaM binding in live cells.
PKC regulates many aspects of mGluR5 function. Early studies
have demonstrated that mGluR5 activity elicits high-frequency
Ca2 oscillations that are PKC-dependent. These oscillations are
regulated by the direct phosphorylation of themGluR5C terminus,
with phosphorylation of S839 being required (8, 10). We now show
that phosphorylation of a second site, S901, is a key mechanism in
the regulation of mGluR5-mediated high-frequency Ca2 oscilla-
tions. These data strongly suggest that the effect of PKC phosphor-
ylation of S901 onCa2oscillations ismediated by phosphorylation-
dependent decreases in mGluR5 surface expression.
CaM interacts with ionotropic glutamate receptors in addition to
mGluRs. CaMbinding toNMDAreceptors regulates both receptor
localization and channel function, thereby contributing to the
modulation of synaptic plasticity (17, 23, 24, 33, 34). CaM binding
Fig. 5. S901 phosphorylation regulates Ca2 os-
cillation frequency and decay time in mGluR5-
expressing HeLa cells. (A) Representative Ca2 os-
cillationpatterns inducedbymGluR5wild-typeand
mGluR5 S901A. HeLa cells expressing mGluR5 wild-
type or S901A were loaded with fura-2-AM and
incubated with glutamate (100 M). Ca2 oscilla-
tions were analyzed by using a ratiometric spec-
trofluorophotometer. (B) Histograms of Ca2oscil-
lation frequency in HeLa cells expressing mGluR5
wild-type or mGluR5 S901A (n  27 for wild-type;
n  23 for S901A). The data are represented as
means  SD. (C) Histograms of Ca2 oscillation
decay half-life in HeLa cells expressing mGluR5
wild-type or mGluR5 S901A (n  27 for wild-type;
n 20 for S901A).
Fig. 6. Model of PKC–CaM regulation of mGluR5 surface expression. Our data support a model in which competition between PKC phosphorylation of S901 and CaM
binding to S901 on mGluR5 determines trafficking of mGluR5 (Left). CaM binding acts to stabilize receptor surface expression (Middle), whereas PKC phosphorylation
of S901 inhibits CaM binding and decreases receptor surface expression (Right).








to receptors often competes with other protein–protein interac-
tions, and CaM competition with spectrin, and -actinin binding to
NMDA receptors is one such example (17, 24, 33, 34). Similarly, it
has also been shown that CaM binding to mGluR5 inhibits the
binding of the E3 ligase Siah-1A in vitro (13). Recently Siah-1A has
been shown to promotemonoubiquitination of-synuclein, leading
to its aggregation (35). It is possible that the effects of CaM on
mGluR5 trafficking observed in our study are a consequence of
changes in Siah-1A-dependent ubiquitination ofmGluR5; however,
direct evidence for this hypothesis awaits further experimentation.
Our findings suggest that the ability of CaM to regulate the
binding activities of glutamate receptor-interacting proteins at
excitatory synapses may allow it to act as a signal integrator or
modulator of glutamate receptor-induced synaptic plasticity. As we
now show for mGluR5, the rapid Ca2-dependent regulation of
CaM binding mediates receptor expression at synapses and will
likely regulate mGluR5-dependent processes in vivo as well.
Methods
Detailed information on TIRFM, DNA constructs, antibodies, and additional
methods is available in supporting information (SI) Methods.
ELISA for Quantification of Receptor Surface Expression. HeLa cells were grown
to60% confluence on 24-well tissue culture dishes and transfected with wild-
type Myc–mGluR5 or Myc–mGluR5 S901A. After 36–48 h, cells were washed in
modified HBSS and allowed to equilibrate for at least 30 min at 37°C. Cells were
treated with 500 M L-glutamate for the indicated time intervals. The cells were
washed, fixed with 4% paraformaldehyde in PBS for 5 min at room temperature,
and washed again, and nonspecific binding was blocked with 1% BSA/PBS for 45
min. Cells were incubated with Myc antibody (9E10) diluted 1:1,000 in 1%
BSA/PBS for 60 min, washed, and blocked again with 1% BSA/PBS for 15 min and
incubated for 60 min with anti-mouse IgG–HRP (Amersham Biosciences) diluted
1:5,000 in 1% BSA. Cells were washed and incubated with the colorimetric
horseradish peroxidase substrate O-phenylenediamine dihydrate (1 mg/ml;
Sigma) in OPD buffer (50 mM citric acid, 65 mM sodium phosphate, and 0.03%
hydrogen peroxide, pH 5.0) with gentle shaking for 12 min. An equal volume of
0.1N H2SO4 was added to stop the reaction. The optical density of each well was
determined by using a microplate reader at 492 nm. The value obtained for
untransfected cells was subtracted as background optical density.
Receptor Trafficking in Neurons. A fluorescence-based antibody uptake inter-
nalization assay was performed as described previously (36), with some modifi-
cations. Cultured hippocampal neurons prepared from E18 Sprague–Dawley rats
were transfected with Myc–mGluR5 (wild-type or S901A) and mRFP–CaM or
mRFP alone by using Ca2phosphate coprecipitation. After 2 days, Myc antibody
was added to the media to label surface-expressed mGluR5 for 45 min. Neurons
were washed with PBS twice and then treated with the group I mGluR agonist
DHPG (100 M) for 30 min at 37°C or with conditioned media alone at room
temperature. After washing with PBS, the cells were fixed with 4% paraformal-
dehyde/4% sucrose in PBS for 15 min. Neurons were incubated with Alexa
633-conjugated (red) anti-mouse secondary antibody (Molecular Probes) for 30
min at room temperature to label the surface receptors and were washed,
followed by permeabilization with 0.25% Triton X-100 for 5 min. After blocking
with 10% normal goat serum, neurons were incubated with Alexa 488-
conjugated (green) anti-mouse secondary antibody (Molecular Probes) for 30
min to label intracellular pools of receptors. After washing with PBS, ProLong
Antifade reagent (Molecular Probes) was applied to neurons before mounting.
Images were analyzed with a40 objective on an LSM 510 confocal microscope
(Zeiss).Alexa488dyewasexcitedwitha488-nmAr laserandappearedgreen.The
Alexa 633 dye (excited with a 633 nm HeNe laser) was presented as red for
clarification. mRFP (Invitrogen) was excited with a 543-nm HeNe laser and pre-
sented as white. No crosstalk between channels was detected under these set-
tings. Series of optical sections were collected at intervals of 0.4 m. The figures
show maximum projections. For quantitative analysis, images from three or four
dendritesperneuron(at least15neuronsperexperiment)werecollected,andthe
amount of internalization was measured based on the data collected in three
independent experiments with MetaMorph 6.0 software (Universal Imaging
Corp.). The values represent meansSEM. Significance was determined by using
a Student’s unpaired t test.
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